TRESIBA
Live / Registered — Registered — Section 71 accepted (as of 23 Dec 2020)
What this means for you
Registered since 31 Aug 2010. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 31 Aug 2030: the §71 ten-year affidavit of use).
Record
- Serial number
- 79080004
- Registration number
- 3841743
- Mark type
- Word mark
- Filed
- 03 Feb 2010
- Published for opposition
- 15 Jun 2010
- Registered
- 31 Aug 2010
- Next maintenance filing
- §71 ten-year affidavit of use, due by 31 Aug 2030 (grace period to 28 Feb 2031)
- Attorney of record
- Claudia A. Smith
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diabetes
Owner
- Novo Nordisk A/S, Bagsværd, DK
- Novo Nordisk A/S, DK
- Novo Nordisk A/S, DK
Prosecution history
- 23 Dec 2020 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 23 Dec 2020 — REGISTERED-SEC.71 ACCEPTED
- 17 Nov 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Jun 2020 — TEAS SECTION 71 RECEIVED
- 20 Feb 2020 — INTERNATIONAL REGISTRATION RENEWED
- 31 Aug 2019 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 27 Sept 2016 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 27 Sept 2016 — REGISTERED-SEC.71 ACCEPTED
- 27 Sept 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 Aug 2016 — TEAS SECTION 71 RECEIVED
- 31 Aug 2010 — REGISTERED-PRINCIPAL REGISTER
- 15 Jun 2010 — PUBLISHED FOR OPPOSITION
- 26 May 2010 — NOTICE OF PUBLICATION
- 13 May 2010 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 13 May 2010 — ASSIGNED TO LIE